David R. Thomas, M.D., and John E. Morley, M.D.
During the last three years, Dr. Thomas has received grant/research support from Nestle. During the last three years, Dr. Morley has received grant/research support from Vivus, Merck & Co., Pharmacia, B. Braun McGaw, Bayer Corp and Nestec, Ltd. He has also served on the Speakers' Bureau for LXN, Organon, Ross, Pharmacia, GlaxoSmithKline, Aventis, Searle, Roche, Bristol-Myers Squibb, Novartis, Pratt, B.Braun McGaw, Pfizer and Solvay.
This Cyberounds® is published simultaneously in the Supplement to the July 2002 issue of Annals of Long-Term Care, in cooperation with the Council for Nutritional Clinical Strategies in Long-Term Care, which received an unrestricted educational grant from Solvay Pharmaceuticals, Inc.
Estimated time to complete:
Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Albert Einstein College of Medicine is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing medical
education for physicians.
Upon completion of this Cyberounds®
, you should be able to:
- Discuss the high prevalence of malnutrition in older persons
- List the effects and side effects of different orexigenics
- Discuss the rationale for treating malnutrition in older persons.